{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:05:08Z","timestamp":1777622708990,"version":"3.51.4"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T00:00:00Z","timestamp":1405641600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0102370","type":"journal-article","created":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T18:43:09Z","timestamp":1405708989000},"page":"e102370","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Absence of BRCA\/FMR1 Correlations in Women with Ovarian Cancers"],"prefix":"10.1371","volume":"9","author":[{"given":"Norbert","family":"Gleicher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaly A.","family":"Kushnir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Guang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Lazzaroni-Tealdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Barad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,7,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e44753","DOI":"10.1371\/journal.pone.0044753","article-title":"BRCA1\/2 mutations appear embryo-lethal unless rescued by low (CGGn&lt;26) FMR1 sub-genotypes: Explanation for the \u201cBRCA Paradox\u201d?","volume":"7(9)","author":"A Weghofer","year":"2012","journal-title":"PLoS ONE"},{"key":"ref2","first-page":"1480151","article-title":"Association of BRCA1\/2 mutations with FMR1 genotypes: effects on menarcheal and menopausal age","volume":"75","author":"MK Tea","year":"2013","journal-title":"Maturitas"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e15303","DOI":"10.1371\/journal.pone.0015303","article-title":"FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance","volume":"15","author":"N Gleicher","year":"2010","journal-title":"PLoS ONE"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of <italic>BRCA1<\/italic> mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks","volume":"28","author":"K Oktay","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/sj.onc.1209871","article-title":"Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects","volume":"25","author":"B Evers","year":"2006","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0140-6736(05)63327-2","article-title":"P53 mutations in BRCA1-associated familial breast cancer","volume":"350","author":"T Crook","year":"1997","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1098-2264(199702)18:2<102::AID-GCC4>3.0.CO;2-6","article-title":"Mutations and alternative splicing of the BRCA gene in UK breast\/ovarian cancer families","volume":"18","author":"CF Xu","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1101\/gad.1050003","article-title":"Senescence, aging, and malignant transformation mediated by p53 in mice lacking BRCA1 full-length isoform","volume":"17","author":"L Cao","year":"1993","journal-title":"Genes Dev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ng0797-298","article-title":"Partial rescue of Brca1 (5 6) early embryonic lethality by p53 p21 null mutation","volume":"16","author":"R Hakem","year":"1997","journal-title":"Nat Genet"},{"key":"ref10","first-page":"764","article-title":"Targeted of breast cancer suspectibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1\/brca2, Brca1.p53, and Brca2\/p53 nullizygous embryos","volume":"97","author":"T Ludwig","year":"1997","journal-title":"Genes Dev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"N Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/humrep\/det254","article-title":"FMR1 low sub-genotype does not rescue BRCA1\/2-mutated human embryos and does not explain primary ovarian insufficiency among BRCA1\/2-carriers","volume":"28","author":"RD Brand\u00e3o","year":"2013","journal-title":"Hum Reprod"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ejhg.2013.281","article-title":"BRCA1\/2 mutations and FMR1alleles are randomly distributed: a case control study","volume":"22","author":"E Dagan","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ejhg.2013.193","article-title":"The FMR1 CGG repeat test is not a candidate prescreening tool for identifying women with a high probability of being carriers of BRCA mutations","volume":"22","author":"MT Ricci","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ejhg.2013.213","article-title":"Do BRCA1\/2 mutations and low FMR1 alleles interact or not?","volume":"22","author":"N Gleicher","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"ref16","first-page":"297","article-title":"Founder <italic>BRCA1<\/italic>\/2 mutations in Europe: implications for hereditary-breast-ovarian cancer prevention and control","volume":"1","author":"R Janavivi\u010dius","year":"2010","journal-title":"EPMA J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0959-8049(01)00244-1","article-title":"Large regional differences in the frequency of distinct BRCA1\/BRCA2 mutations in 517 Dutch breast and\/or ovarian cancer families","volume":"37","author":"LC Verhooh","year":"2001","journal-title":"Eur J Cancer"},{"key":"ref18","first-page":"172ra21","article-title":"Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans","volume":"13","author":"S Titus","year":"2013","journal-title":"Sci Transl Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/humu.22025","article-title":"Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers","volume":"33","author":"SJ Ramus","year":"2012","journal-title":"Hum Mut"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2566","article-title":"Multiple independent variants at the TERT locus associated with telomere length and risks of breast and ovarian cancer","volume":"45","author":"SE Bojesen","year":"2013","journal-title":"Nat Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1003212","DOI":"10.1371\/journal.pgen.1003212","article-title":"Genome-wide association study in BRCA mutation carriers identifies novel loci associated with breast and ovarian cancer risk","volume":"9","author":"FJ Couch","year":"2013","journal-title":"PLoS Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1016\/S0960-9822(02)01430-6","article-title":"X-chromosome inactivation: X marks the spot for BRCA1","volume":"13","author":"C Stone","year":"2003","journal-title":"Curr Biol"},{"issue":"100","key":"ref23","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/jnci\/djn345","article-title":"Skewed X chromosome inactivation and breast and ovarian cancer status: Evidence for X-linked modifiers of BRCA1","volume":"Inst","author":"F Lose","year":"2008","journal-title":"J Natl cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e18781","DOI":"10.1371\/journal.pone.0018781","article-title":"Association of FMR1 genotypes with in vitro fertilization (IVF) outcomes based on ethnicity\/race","volume":"1(6)","author":"N Gleicher","year":"2011","journal-title":"PLoS ONE"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0102370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T05:59:10Z","timestamp":1540274350000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0102370"}},"subtitle":[],"editor":[{"given":"Ajay Pratap","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,18]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0102370","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,18]]}}}